Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke
2015
Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase
2012
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Blood Pressure as an Independent Prognostic Factor in Acute Ischemic Stroke
2006
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Intracerebral haemorrhage
2009 Standout
Discriminatory ability of bone mass measurements (SPA and DEXA) for fractures in elderly postmenopausal women
1992
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Risk factors for osteoporosis
1992
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
1993
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Precision in assessment of osteoporosis from spine radiographs
1991
Calcium and osteoporosis
1997
Metabolic and functional consequences of urinary reconstruction with bowel
2003
Design of the Fracture Intervention Trial
1993
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosis
1994
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials
1997
Neuroprotection for ischemic stroke: Past, present and future
2008
Comparison of the European and USA Practice Guidelines for Osteoporosis
2000
Effect of Vitamin D Supplementation on Wintertime and Overall Bone Loss in Healthy Postmenopausal Women
1991
Vitamin D Deficiency
2007 Standout
Prediction of fracture from low bone mineral density measurements overestimates risk
2000
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Lack of correlation of free deoxypyridinoline excretion with Taq1 restriction length polymorphisms in the vitamin D receptor gene in males
1998
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Validation of body composition by dual energy X‐ray absorptiometry (DEXA)
1991
Relationship between Blood Pressure and Outcomes in Acute Ischemic Stroke Patients Administered Lytic Medication in the TIMS-China Study
2016
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
A family history of fracture and fracture risk: a meta-analysis
2004
Intra-arterial Prourokinase for Acute Ischemic Stroke
1999 Standout
Treatment of Postmenopausal Osteoporosis
1998
Treatment of postmenopausal osteoporosis
2002
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2008
Postmenopausal bone loss in Japanese women
1995 StandoutNobel
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2004
Factors influencing acute blood pressure values in stroke subtypes
2004
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke
2005
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
2003 Standout
The therapeutic potential of regulated hypothermia
2001
Platelet Activation and Atherothrombosis
2007 Standout
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis
1995
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Mechanisms, challenges and opportunities in stroke
2003
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden
2000
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
2002
V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women
2002
Stroke
2008 Standout
Glial and neuronal control of brain blood flow
2010 StandoutNature
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
1994
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]
2003
Epidemiology of Hip Fractures
1997
Influence of aging and menopause in determining vertebral and distal forearm bone loss in adult healthy women
1993
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Subclinical Thyroid Disease
2004 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Tirilazad for acute ischaemic stroke
2001
Outcome variables in osteoporosis trials
1992
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The influence of alcohol consumption on the risk of vertebral deformity
1997
Abnormalities on ECG and telemetry predict stroke outcome at 3 months
2005
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke
2006
Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study
1998
Evaluation of the risk of hip fracture
1996
Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial
2006
Vertebrobasilar thrombosis
1996
A clinical trial on the effects of a combination of elcatonin (Carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women
1993
Structural Bases of Desensitization in AMPA Receptor-Auxiliary Subunit Complexes
2017 StandoutNobel
Risk of Stroke-Associated Pneumonia and Oral Hygiene
2015
Biochemical Markers of Bone Metabolism: An Overview
1997
Treatment of Traumatic Brain Injury with Moderate Hypothermia
1997 Standout
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial
2012
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Prevention of falls and consequent injuries in elderly people
2005 Standout
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis
1993
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Relationship of Bone Turnover to Bone Density and Fractures
1997
Combating Hyperthermia in Acute Stroke
1998
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
1996
Intravenous thrombolysis for acute stroke
1997
Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures
1995
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Prevention of Nonvertebral Fractures by Alendronate
1997
Ischemic Stroke and Incomplete Infarction
1996
Thrombolysis in acute ischemic stroke: does it work?
1992
Blood Pressure Decrease During the Acute Phase of Ischemic Stroke Is Associated With Brain Injury and Poor Stroke Outcome
2004
Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women
1999
Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.
1994
Open Trial of Intravenous Tissue Plasminogen Activator in Acute Carotid Territory Stroke
1996
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
1996
Association of Characteristics of Blood Pressure Profiles and Stroke Outcomes in the ECASS-II Trial
2007
Bladder Cancer
2020 Standout
The Effect of a Single Dose of Osteoprotegerin in Postmenopausal Women
2001
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital.
1999
From Density to Structure: Growing Up and Growing Old on the Surfaces of Bone
1997
Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study
2000
Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment
2016
Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial
1998
Computerized advice on drug dosage to improve prescribing practice
2008
Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women
1998
Neuroprotective Effect of SolCD39, a Novel Platelet Aggregation Inhibitor, on Transient Middle Cerebral Artery Occlusion in Rats
2003
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1996
Influence of Admission Body Temperature on Stroke Mortality
2000
Bone Mass in Prepubertal Children: Gender Differences and the Role of Physical Activity and Sunlight Exposure1
1998
Epidemiology of Spinal Osteoporosis
1997
Universal standardization for dual X-ray absorptiometry: Patient and phantom cross-calibration results
1994
Time Course of Tissue Plasminogen Activator–Induced Recanalization in Acute Cardioembolic Stroke
2001
The Role of Vitamin D in Cancer Prevention
2005 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
1996
Local Intra-Arterial Thrombolysis in Acute Ischemic Stroke
1998
Emergency Physicians
1995
Effect of Paracetamol (Acetaminophen) on Body Temperature in Acute Ischemic Stroke
2001
Timing for Fever-Related Brain Damage in Acute Ischemic Stroke
1998
The Neurotoxicity of Tissue Plasminogen Activator?
2004
Relation of fractional 47Ca retention to season and rates of bone loss in healthy postmenopausal women
1991
Bone Density and Fracture Risk in Men
1998
Apparent Pre- and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort
1997
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
Antithrombotic Therapy for Cerebrovascular Disorders
1995
The Impact of Recanalization on Ischemic Stroke Outcome
2007 Standout
Bone metabolism and disease in chronic kidney disease
2003
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Admission Body Temperature Predicts Long-Term Mortality After Acute Stroke
2002
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of Karsten Overgaard being referenced
Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset
2010
Effect of salcatonin given intranasally on early postmenopausal bone loss.
1989
Dysphagia Screening and Intensified Oral Hygiene Reduce Pneumonia After Stroke
2013
Fatal ischaemic brain oedema after unsuccessful thrombolysis
1990
The effects of early insulin treatment combined with thrombolysis in rat embolic stroke
2002
Bone metabolism following bladder substitution with the ileal urethral Kock reservoir
1997
Effect of hypothermia and delayed thrombolysis in a rat embolic stroke model
2009
The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis
1994
Bone mass measured by photon absorptiometry: comparison of forearm, heel, and spine
1990
The course of blood pressure in acute stroke is related to the severity of the neurological deficits
2002
Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model
1993
High bone turnover is associated with low bone mass in both pre- and postmenopausal women
1996
Lack of seasonal variation in bone mass and biochemical estimates of bone turnover
1988
No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis
1992
Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up Study
1996
Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers
1994
Potential risk factors for development of postmenopausal osteoporosis — Examined over a 12-year period
1991
Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy
1995
Comparison of bone densitometry of the phalanges, distal forearm and axial skeleton in early postmenopausal women participating in the EPIC study
1996
NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS
1989
Effects of computer-assisted oral anticoagulant therapy
2012
The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model
1994
Thrombolysis in ischaemic stroke — how far from a clinical breakthrough ?
1995
Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study
1994
Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.
1992
[Can acute stroke be treated with hypothermia?].
1998
Bone metabolism in premenopausal women with nontoxic goiter and reduced serum thyrotropin levels.
1994
Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
1993
Is heritability a risk factor for postmenopausal osteoporosis?
1992
Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine.
1990
Thrombolytic therapy in acute ischemic stroke. A Danish pilot study.
1993
The impact of degenerative conditions in the spine on bone mineral density and fracture risk prediction
1996
Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: Long‐term effects on bone, calcium and lipid metabolism, climacteric symptoms and bleeding
1992
Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
1991
Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model.
1992
Evaluation of a new commercial IRMA for bone-specific alkaline phosphatase during treatment with hormone replacement therapy and calcitonin
1996
Spontaneous postmenopausal bone loss in different skeletal areas—followed up for 15 years
1995
Effect of Early Treatment with Tirilazad (U74006F) Combined with Delayed Thrombolytic Therapy in Rat Embolic Stroke
1996
Effects of Citicoline Combined With Thrombolytic Therapy in a Rat Embolic Stroke Model
1999